These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 18997479)

  • 1. Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.
    Addolorato G; Leggio L; Hopf FW; Diana M; Bonci A
    Neuropsychopharmacology; 2012 Jan; 37(1):163-77. PubMed ID: 22030714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-specific dissociations in autonomic and HPA responses to stress and cues in alcohol-dependent patients with cocaine abuse.
    Fox HC; Hong KI; Siedlarz KM; Bergquist K; Anderson G; Kreek MJ; Sinha R
    Alcohol Alcohol; 2009; 44(6):575-85. PubMed ID: 19793926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-type Ca2+ channels mediate cardiovascular symptoms of alcohol withdrawal in humans.
    Kähkönen S; Bondarenko BB
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):45-8. PubMed ID: 14687856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide mediates cardiovascular symptoms in alcohol withdrawal.
    Kähkönen S; Boris B; Edwin Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):761-5. PubMed ID: 17291656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawal.
    Kähkönen S; Bondarenko B; Lipsanen J; Zvartau E
    Int J Psychophysiol; 2007 Dec; 66(3):225-30. PubMed ID: 17761330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alcohol withdrawal on cardiovascular system.
    Kähkönen S; Zvartau E; Lipsanen J; Bondarenko B
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):550-3. PubMed ID: 21185902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of verapamil, an antagonist of L-type calcium channels, on cardiovascular symptoms in alcohol withdrawal.
    Kähkönen S; Bondarenko BB; Lipsanen J; Zvartau EE
    Neuropsychobiology; 2008; 58(3-4):123-7. PubMed ID: 18997479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses to cardiovascular drugs during alcohol withdrawal.
    Kähkönen S
    Alcohol Alcohol; 2006; 41(1):11-3. PubMed ID: 16260447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of cardiovascular dysregulation during alcohol withdrawal.
    Kähkönen S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):937-41. PubMed ID: 15380854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockers in shock.
    Hess ML; Mahany TM; Greenfield LJ
    Prog Clin Biol Res; 1983; 111():271-82. PubMed ID: 6346331
    [No Abstract]   [Full Text] [Related]  

  • 11. Verapamil.
    Ruedy J
    Clin Invest Med; 1981; 4(2):129-47. PubMed ID: 7026099
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.